Skip to main content
. 2016 May 30;7(28):43868–43893. doi: 10.18632/oncotarget.9701

Table 5. Protein complexes over-represented in Stage IIIB DEPs.

Complexes Up Down Total
gene count q-value gene count q-value gene count q-value
Nop56p-associated pre-rRNA complex 5 (4.7%) 4.12E-04 NA NSS NA NSS
HMGB1-HMGB2-HSC70-ERP60-GAPDH complex 2 (40.0%) 7.83E-04 NA NSS NA NSS
CDCA5-PDS5A-RAD21-SMC1A-PDS5B-SMC3 complex 2 (33.3%) 7.83E-04 NA NSS NA NSS
L1:ALCAM NA NSS 2 (100.0%) 4.44E-04 NA NSS
alcohol dehydrogenase 1 (class I), alpha/beta dimer NA NSS 2 (66.7%) 4.44E-04 NA NSS
Laminin-221 NA NSS 2 (66.7%) 4.44E-04 NA NSS
alpha7×1/beta1 Integrin/Laminin 2 NA NSS 2 (40.0%) 5.51E-04 NA NSS
alpha7×1/beta1 Integrin/Laminin 11 NA NSS 2 (40.0%) 5.51E-04 NA NSS
alpha6/beta1 Integrin/Laminin 4 NA NSS 2 (40.0%) 5.51E-04 NA NSS
alpha6/beta4 Integrin/Laminin 4 NA NSS 2 (40.0%) 5.51E-04 NA NSS
alpha3/beta1 Integrin/Laminin 4 NA NSS 2 (40.0%) 5.51E-04 NA NSS

The percentages in the parentheses reflect the proportion of the over-represented genes of the input to the total gene number of corresponding protein complexes. NA, not available, NSS, not statistically significant.